Journal: Journal of Crohn's & colitis
Article Title: Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.
PMID/MRN: 27816934
Publication Date: 2016-Nov-05
Abstract:
There is a need for better, less-invasive disease activity indices that provide a representative assessment of endoscopic disease activity. We developed a new clinical score that incorporates the Harvey-Bradshaw index [HBI] with modified patient-reported outcomes [PRO p ] and physician [clinician]-reported outcomes [PRO c ] and assessed its ability to measure endosopic disease activity in ileocolonic Crohn's disease [CD].
A cohort of 88 CD patients undergoing colonoscopy was accrued in a prospective fashion. In total, 48 of the subjects were CD cases and 40 had already undergone a post-operative ileocolonic resection [post-op CD]. Each patient underwent multiple, endoscopist-blinded assessments including: HBI score, a PRO p question asking for patient perception of disease activity status, a PRO c question for clinician perception of disease activity status and C-reactive protein [CRP]. Active endoscopic disease was defined as Simple Endoscopic Score for CD [SES-CD] ³ 3 for CD subjects and Rutgeerts score > i1 for post-op CD subjects.
Clinical remission as defined by the HBI did not accurately reflect endoscopic remission as defined by the SES-CD (area under the curve [AUC] = 0.54). Combining the HBI with PRO p and PRO c scores and then further adding CRP significantly improved the correlation with SES-CD [AUC = 0.78 and AUC = 0.88, respectively, p < 0.00001]. In post-op CD, HBI-defined remission also performed poorly against endoscopic remission defined by the Rutgeerts score [AUC = 0.52]. Combining HBI with PRO p and the PRO c scores and then further adding CRP did not significantly improve the model [AUC = 0.65 and AUC = 0.61, respectively, p = NS].
In CD, the HBI correlates poorly with endoscopic disease activity. However, the HBI-PRO score, which incorporated PRO p , PRO c , CRP and HBI, significantly improved its ability to predict endoscopic activity in ileocolonic CD without prior surgery.
Copyright © 2016 European CrohnÕs and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.